IP Library Granted Patent US 9,481,700
Granted Patent B2
US 9,481,700 · App. 13/916,451 · Granted Nov 1, 2016

Method for preparing isofagomine and its derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,481,700
App. No.
13/916,451
Granted
Nov 1, 2016
Kind
B2
Abstract

A method for preparing isofagomine, its derivatives, intermediates and salts thereof using novel processes to make isofagomine from D-(−)-arabinose and L-(−)-xylose.

Claims (14)

1. A compound of the formula

where PG is a hydroxyl protecting group.

2. The compound of claim 1 , wherein PG is benzyl.

3. A method for preparing isofagomine, a protected isofagomine salt, or an isofagomine acid salt comprising converting the compound of any one of claims 1 to 2 to make isofagomine, a protected isofagomine salt, or an isofagomine acid salt thereof, wherein the conversion comprises:

(i) reducing the compound to a triprotected primary amine; deprotecting the primary amine to a diol; and catalytically hydrogenating the diol; or

(ii) converting the compound to a protected diol and deprotecting the diol; or

(iii) converting the compound to a protected isofagomine salt.

4. The method of claim 3 , wherein converting the compound of the formula

to make isofagomine, a protected isofagomine salt, or an isofagomine acid salt comprises reducing the compound to a triprotected primary amine; deprotecting the primary amine to a diol; and catalytically hydrogenating the diol optionally in the presence of an acid.

5. The method of claim 3 , wherein converting the compound of the formula

to make isofagomine, a protected isofagomine salt, or an isofagomine acid salt comprises converting the compound to a protected diol and deprotecting the diol.

6. The method of claim 3 , wherein the compound of the formula

is converted to a protected isofagomine salt.

7. The method of claim 6 , further comprising deprotecting the protected isofagomine salt.

Assignments (1)
SECURITY INTEREST Recorded Apr 27, 2026
From: BIOMARIN PHARMACEUTICAL INC.; AMICUS THERAPEUTICS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075493/0968 →